3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
57
Carcinoma, Non-Small-Cell Lung
34
Urinary Bladder Neoplasms
29
Neoplasm Metastasis
20
Lung Neoplasms
19
Ovarian Neoplasms
18
Lymphoma, Large B-Cell, Diffuse
18
Cholangiocarcinoma
15
Biliary Tract Neoplasms
14
Triple Negative Breast Neoplasms
13
Neoplasms
13
Nasopharyngeal Carcinoma
13
Colorectal Neoplasms
12
Breast Neoplasms
12
Carcinoma, Transitional Cell
11
Non-Muscle Invasive Bladder Neoplasms
10
Recurrence
9
Fallopian Tube Neoplasms
9
Gallbladder Neoplasms
8
Sarcoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Bile Duct Neoplasms
6
Osteosarcoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Endometrial Neoplasms
5
Uterine Cervical Neoplasms
4
Melanoma
4
Hodgkin Disease
4
Colonic Neoplasms
4
Interventions
Magnetic Resonance Spectroscopy
12
Specimen Handling
11
Cisplatin
9
Radiotherapy, Intensity-Modulated
7
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
pembrolizumab
5
Cetuximab
5
Carboplatin
5
Radiation
4
Biopsy
4
(225)Ac-DOTA-c(RGDyK)
4
Taxes
3
Radiotherapy
3
Paclitaxel
3
ipatasertib
2
cemiplimab
2
X-Rays
2
Interviews as Topic
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
toripalimab
1
peposertib
1
merphos
1
durvalumab
1
dehydroftorafur
1
cabozantinib
1
atezolizumab
1
Tretinoin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
Gemcitabine
×
90 days
×
Clear all
No trials found.